Market Place
Sourcing Support
All News #Library
Biotech
AVROBIO to Explore Strategic Alternatives
12 Jul 2023 //
BUSINESSWIRE
Novartis Buys Avrobio Gene Therapy for $88 Million
31 May 2023 //
CONTRACT PHARMA
Novartis to buy Avrobio gene therapy for $88M, ending M&A rumor
23 May 2023 //
FIERCE BIOTECH
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5M
22 May 2023 //
BUSINESSWIRE
AVROBIO Announces Data from Phase 1/2 Clinical Trial of Cystinosis at ASGCT
18 May 2023 //
BUSINESSWIRE
AVROBIO Reports First Quarter 2023 Financial Results
11 May 2023 //
BUSINESSWIRE
AVROBIO to Present Data from Lysosomal Disorder Gene Therapy Pipeline
09 Feb 2023 //
BUSINESSWIRE
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.